Biocept (BIOC) Misses Q3 EPS by $0.03

Biocept (NASDAQ: BIOC) reported Q3 EPS of $0.03, $0.03 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.07 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• JPMorgan Starts Hyundai Department Store (069960:KS) at Overweight
• BWS Financial Starts Capstone Energy Plus (CEPL) at Buy